US6406491B1 - Compliant transmyocardial implant - Google Patents

Compliant transmyocardial implant Download PDF

Info

Publication number
US6406491B1
US6406491B1 US09/304,650 US30465099A US6406491B1 US 6406491 B1 US6406491 B1 US 6406491B1 US 30465099 A US30465099 A US 30465099A US 6406491 B1 US6406491 B1 US 6406491B1
Authority
US
United States
Prior art keywords
vessel
myocardial
conduit
myocardium
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/304,650
Inventor
Guy P. Vanney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Horizon Technology Funding Co LLC
Original Assignee
HeartStent Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HeartStent Corp filed Critical HeartStent Corp
Assigned to HEARTSTENT CORPORATION reassignment HEARTSTENT CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VANNEY, GUY P.
Priority to US09/304,650 priority Critical patent/US6406491B1/en
Priority to JP2000614922A priority patent/JP2002542882A/en
Priority to GB0128782A priority patent/GB2369064A/en
Priority to AU39252/00A priority patent/AU3925200A/en
Priority to PCT/US2000/008105 priority patent/WO2000066035A1/en
Priority to DE10084450T priority patent/DE10084450T1/en
Publication of US6406491B1 publication Critical patent/US6406491B1/en
Application granted granted Critical
Assigned to PERCARDIA, INC. reassignment PERCARDIA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEARTSTENT CORPORATION
Assigned to HORIZON TECHNOLOGY FUNDING COMPANY LLC reassignment HORIZON TECHNOLOGY FUNDING COMPANY LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PERCARDIA, INC.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/064—Blood vessels with special features to facilitate anastomotic coupling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493—Transmyocardial revascularisation [TMR] devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94—Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel

Definitions

  • This invention pertains to an implant for passing blood flow directly between a chamber of the heart and a coronary vessel. More particularly, this invention pertains to such an implant with an enhanced design for enhanced compliance of a transmyocardial conduit in a coronary vessel.
  • the conduit penetrates into the left ventricle in order to prevent tissue growth and occlusions over an opening of the conduit.
  • 08/944,313 filed Oct. 6, 1997, entitled “Transmyocardial Implant”, and filed in the name of inventors Katherine S. Tweden, Guy P. Vanney and Thomas L. Odland, teaches an implant such as that shown in the aforementioned '682 patent with an enhanced fixation structure.
  • the enhanced fixation structure includes a fabric surrounding at least a portion of the conduit to facilitate tissue growth on the exterior of the implant.
  • This application has the same disclosure as PCT/US 98/17310.
  • Implants such as those shown in the aforementioned patent and applications include a portion to be placed within a coronary vessel and a portion to be placed within the myocardium.
  • the vessel When placing a portion of the implant in the coronary vessel, the vessel is incised a length sufficient to insert the implant.
  • the implant When placed within the coronary vessel, the implant discharges flow axially into the vessel.
  • a portion of the coronary artery is dissected.
  • the dissected portion is incised and the vessel portion of the implant is inserted into the lumen.
  • a stay suture secures the artery to the implant.
  • the stay suture is paced around the artery and vessel portion a distanced spaced from the open end of the vessel portion.
  • the implant is rigid.
  • the vessel is compliant. Since the vessel is radially flexing over time, the compliance mismatch between the vessel portion and the vessel may damage the vessel.
  • a transmyocardial implant for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vessel.
  • the implant includes a hollow rigid conduit having a vessel portion and a myocardial portion.
  • the vessel portion is sized to be inserted into the vessel.
  • the myocardial portion is sized to extend from the vessel portion and through the myocardium into the chamber.
  • the conduit has open vessel and myocardial ends on respective ones of the vessel and myocardial portions to define a blood flow pathway within an interior of the conduit between the vessel and myocardial ends.
  • the myocardial portion is formed of a conduit material sufficiently rigid to resist deformation and closure of the pathway in response to contraction of the myocardiurn.
  • the vessel portion has a radial compliance approximating a radial compliance of the vessel.
  • FIG. 1 is a side elevation view of a transmyocardial conduit according to the present invention and showing a myocardial portion of the implant placed through a heart wall and with a vessel portion placed in a coronary vessel; and
  • FIG. 2 is a side sectional view of a vessel portion of the conduit of FIG. 1 placed in a coronary vessel with a coiled end of the vessel portion held in a constricted state.
  • a transmyocardial conduit 10 is shown in the form of an L-shaped rigid tube.
  • the conduit 10 is titanium but may be any other rigid biocompatible material such as pyrolytic carbon or may be titanium coated with pyrolytic carbon.
  • the material of the conduit 10 is preferably a rigid material in order to withstand contraction forces of the myocardium.
  • the tube will have an outside diameter of about 2.5 millimeters and an internal diameter of about 2.0 millimeters to provide a wall thickness of about 0.25 millimeters.
  • the conduit 10 has a first or vessel portion 12 sized to be received within the lumen of a coronary vessel such as the lumen 80 of a coronary artery 82 .
  • the conduit has a second or myocardial portion 14 extending at an angle to the axis of portion 12 .
  • the myocardial portion 14 is sized to extend from the coronary artery 82 directly through the myocardium (heart wall) 84 and protrude into the left ventricle 86 of a patient's heart.
  • the vessel portion 12 has a vessel opening 16 .
  • the myocardial portion 14 has a myocardial opening 18 in communication with an interior 19 (shown in FIG. 2) of the implant 10 . Therefore, blood can freely flow through the conduit 10 between the left ventricle 86 and the lumen 80 of the coronary artery 82 . Blood flows axially out of opening 16 parallel with the axis of lumen 80 .
  • the myocardial portion 14 may be provided with a tissue-growth inducing material such as a polyester sleeve 15 to immobilize the implant 10 within the myocardium 84 .
  • the compliant structure 20 includes a tubular member 22 connected to a radially flexible coil 24 .
  • the vessel portion 12 includes an annular groove 26 .
  • the tubular member 22 slips or is press-fit into the groove 26 .
  • the coil 24 is preferably four individual coils 28 extending from the tubular member in a cantilevered fashion at 90° spacings about the circumference of the tubular member 22 .
  • the individual coils 28 expand for the coil 24 to assume a conical shape (shown in FIG. 1) with a narrow end at the tubular member 22 .
  • the coil 24 expands to a diameter about 0.75 mm larger than the coil's narrow diameter.
  • coils 28 include axially extending fingers which expand radially outwardly and lattice structured stents.
  • a sleeve 32 of thin tear-away plastic with a handle 34 surrounds the coil 24 .
  • the sleeve 32 compresses the coil 24 from the conical shape of FIG. 1 to a cylindrical shape illustrated in FIG. 2 .
  • a surgeon dissects a portion of the artery 82 away from the myocardium 84 .
  • the surgeon ligates the artery 82 distal to an obstruction 87 with sutures 85 .
  • the surgeon then forms an incision through the artery 82 distal to the ligating suture 85 .
  • the coil 24 (compressed by sleeve 32 ) is slipped into the lumen 80 through the open end 82 a of the artery 82 .
  • a stay suture 83 is placed around the vessel 82 over the vessel portion 12 .
  • the sleeve 32 is peeled away by pulling on handle 34 permitting the coil 24 to expand.
  • the expansion causes a corresponding expansion of the lumen 80 at the incised artery end 82 a (FIG. 1 ).
  • the amount of enlargement of the artery 82 is a function of the natural swelling of the artery.
  • the coil 24 is flexible and is radially compressible to compress and expand in response to compression and expansion of the artery 82 .
  • the compliance of the vessel portion 12 now more closely matches a compliance of the artery.
  • the compliance matching is achieved by material selection and geometry of the individual coils 28 for the coil 24 to have a compliance approximating arterial compliance. Such compliance is about 10 ⁇ 10 ⁇ 2 % radial change per 1 mmHg.

Abstract

A transmyocardial implant includes a hollow rigid conduit having a vessel portion and a myocardial portion. The vessel portion is sized to be inserted into a coronary vessel. The myocardial portion is sized to extend from the vessel portion and through a myocardium into a heart chamber. The conduit has open vessel and myocardial ends on respective ones of the vessel and myocardial portions to define a blood flow pathway within an interior of the conduit between the vessel and myocardial ends. The myocardial portion is formed of a conduit material sufficiently rigid to resist deformation and closure of the pathway in response to contraction of the myocardium. The vessel portion has a radial compliance approximating a radial compliance of the vessel.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention pertains to an implant for passing blood flow directly between a chamber of the heart and a coronary vessel. More particularly, this invention pertains to such an implant with an enhanced design for enhanced compliance of a transmyocardial conduit in a coronary vessel.
2. Description of the Prior Art
Commonly assigned U.S. Pat. No. 5,755,682 and PCT International Publication No. WO 98/06356 teach an implant for defining a blood flow conduit directly from a chamber of the heart to a lumen of a coronary vessel. An embodiment disclosed in the aforementioned patent and application teaches an L-shaped implant. The implant is a conduit having one leg sized to be received within a lumen of a coronary artery and a second leg sized to pass through the myocardium and extend into the left ventricle of the heart. As disclosed in the above-referenced patent and application, the conduit remains open for blood flow to pass through the conduit during both systole and diastole. The conduit penetrates into the left ventricle in order to prevent tissue growth and occlusions over an opening of the conduit. 08/944,313 filed Oct. 6, 1997, entitled “Transmyocardial Implant”, and filed in the name of inventors Katherine S. Tweden, Guy P. Vanney and Thomas L. Odland, teaches an implant such as that shown in the aforementioned '682 patent with an enhanced fixation structure. The enhanced fixation structure includes a fabric surrounding at least a portion of the conduit to facilitate tissue growth on the exterior of the implant. This application has the same disclosure as PCT/US 98/17310.
Implants such as those shown in the aforementioned patent and applications include a portion to be placed within a coronary vessel and a portion to be placed within the myocardium. When placing a portion of the implant in the coronary vessel, the vessel is incised a length sufficient to insert the implant. When placed within the coronary vessel, the implant discharges flow axially into the vessel.
When placing an implant, a portion of the coronary artery is dissected. The dissected portion is incised and the vessel portion of the implant is inserted into the lumen. A stay suture secures the artery to the implant. The stay suture is paced around the artery and vessel portion a distanced spaced from the open end of the vessel portion.
The implant is rigid. The vessel is compliant. Since the vessel is radially flexing over time, the compliance mismatch between the vessel portion and the vessel may damage the vessel.
SUMMARY OF THE INVENTION
According to a preferred embodiment of the present invention, a transmyocardial implant is disclosed for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vessel. The implant includes a hollow rigid conduit having a vessel portion and a myocardial portion. The vessel portion is sized to be inserted into the vessel. The myocardial portion is sized to extend from the vessel portion and through the myocardium into the chamber. The conduit has open vessel and myocardial ends on respective ones of the vessel and myocardial portions to define a blood flow pathway within an interior of the conduit between the vessel and myocardial ends. The myocardial portion is formed of a conduit material sufficiently rigid to resist deformation and closure of the pathway in response to contraction of the myocardiurn.
The vessel portion has a radial compliance approximating a radial compliance of the vessel.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a side elevation view of a transmyocardial conduit according to the present invention and showing a myocardial portion of the implant placed through a heart wall and with a vessel portion placed in a coronary vessel; and
FIG. 2 is a side sectional view of a vessel portion of the conduit of FIG. 1 placed in a coronary vessel with a coiled end of the vessel portion held in a constricted state.
DESCRIPTION OF THE PREFERRED EMBODIMENT
With initial reference to FIG. 1, a transmyocardial conduit 10 is shown in the form of an L-shaped rigid tube. In the preferred embodiment described below, the conduit 10 is titanium but may be any other rigid biocompatible material such as pyrolytic carbon or may be titanium coated with pyrolytic carbon. The material of the conduit 10 is preferably a rigid material in order to withstand contraction forces of the myocardium. By way of example, the tube will have an outside diameter of about 2.5 millimeters and an internal diameter of about 2.0 millimeters to provide a wall thickness of about 0.25 millimeters.
The conduit 10 has a first or vessel portion 12 sized to be received within the lumen of a coronary vessel such as the lumen 80 of a coronary artery 82. The conduit has a second or myocardial portion 14 extending at an angle to the axis of portion 12.
The myocardial portion 14 is sized to extend from the coronary artery 82 directly through the myocardium (heart wall) 84 and protrude into the left ventricle 86 of a patient's heart.
The vessel portion 12 has a vessel opening 16. The myocardial portion 14 has a myocardial opening 18 in communication with an interior 19 (shown in FIG. 2) of the implant 10. Therefore, blood can freely flow through the conduit 10 between the left ventricle 86 and the lumen 80 of the coronary artery 82. Blood flows axially out of opening 16 parallel with the axis of lumen 80.
As discussed more fully in the afore-mentioned commonly assigned and co-pending U.S. Patent application Ser. No. 08/944,313, the myocardial portion 14 may be provided with a tissue-growth inducing material such as a polyester sleeve 15 to immobilize the implant 10 within the myocardium 84.
At least a distal portion of the vessel portion 12 is a compliant structure 20. In the embodiment shown, the compliant structure 20 includes a tubular member 22 connected to a radially flexible coil 24. As shown in FIG. 2, the vessel portion 12 includes an annular groove 26. The tubular member 22 slips or is press-fit into the groove 26.
The coil 24 is preferably four individual coils 28 extending from the tubular member in a cantilevered fashion at 90° spacings about the circumference of the tubular member 22. The individual coils 28 expand for the coil 24 to assume a conical shape (shown in FIG. 1) with a narrow end at the tubular member 22. At the opening 16, the coil 24 expands to a diameter about 0.75 mm larger than the coil's narrow diameter.
Alternatives to coils 28 include axially extending fingers which expand radially outwardly and lattice structured stents.
To facilitate placement in a vessel 82, a sleeve 32 of thin tear-away plastic with a handle 34 surrounds the coil 24. The sleeve 32 compresses the coil 24 from the conical shape of FIG. 1 to a cylindrical shape illustrated in FIG. 2.
A surgeon dissects a portion of the artery 82 away from the myocardium 84.
The surgeon ligates the artery 82 distal to an obstruction 87 with sutures 85. The surgeon then forms an incision through the artery 82 distal to the ligating suture 85.
The coil 24 (compressed by sleeve 32) is slipped into the lumen 80 through the open end 82 a of the artery 82. A stay suture 83 is placed around the vessel 82 over the vessel portion 12. A surgical procedure for placing an implant and tools for such procedure are more fully described in commonly assigned and co-pending U.S. patent application Ser. No. 09/179,711 filed Oct. 27, 1998.
After positioning the implant as shown in FIG. 2, the sleeve 32 is peeled away by pulling on handle 34 permitting the coil 24 to expand. The expansion causes a corresponding expansion of the lumen 80 at the incised artery end 82 a (FIG. 1). The amount of enlargement of the artery 82 is a function of the natural swelling of the artery. More specifically, the coil 24 is flexible and is radially compressible to compress and expand in response to compression and expansion of the artery 82. Accordingly, the compliance of the vessel portion 12 now more closely matches a compliance of the artery. The compliance matching is achieved by material selection and geometry of the individual coils 28 for the coil 24 to have a compliance approximating arterial compliance. Such compliance is about 10×10−2% radial change per 1 mmHg.
From the foregoing, the invention has been described in a preferred embodiment. Modifications and equivalents of the disclosed concepts are intended to be included within the scope of the claims.

Claims (9)

What is claimed is:
1. A transmyocardial implant for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vessel, said implant comprising:
a hollow rigid conduit having a vessel portion and a myocardial portion, said vessel portion sized to be inserted into said vessel, said myocardial portion sized to extend from the vessel portion and through said myocardium into said chamber;
said conduit having open vessel and myocardial ends on respective ones of said vessel and myocardial portions to define a blood flow pathway within an interior of said conduit between said vessel and myocardial ends;
said myocardial portion of said conduit formed of a conduit material sufficiently rigid to resist deformation and closure of said pathway in response to contraction of said myocardium;
at least a portion of said vessel portion having a radial compliance approximating a radial compliance of said vessel.
2. An implant according to claim 1 wherein said portion of said vessel portion is an open construction flexible member.
3. An implant according to claim 1 wherein said portion of said vessel portion is radially compressible.
4. An implant according to claim 1, further comprising a delivery system, the delivery system comprising a removable sleeve for holding said portion of said vessel portion in a radially compressed state until after placement of said vessel portion in said artery with said sleeve removable thereafter for said vessel portion to radially expand and contract in response to expansion and contraction of said vessel.
5. An implant according to claim 1 wherein said portion of said vessel portion is a coil.
6. An implant according to claim 1, wherein said portion of said vessel portion has a radial compliance of about 10×10−2% radial change per 1 mmHg.
7. A transmyocardial implant system for establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vessel, said system comprising:
a hollow rigid conduit having a vessel portion and a myocardial portion, said vessel portion sized to be inserted into said vessel, said myocardial portion sized to extend from the vessel portion and through said myocardium into said chamber;
said conduit having open vessel and myocardial ends on respective ones of said vessel and myocardial portions to define a blood flow pathway within an interior of said conduit between said vessel and myocardial ends;
said myocardial portion of said conduit formed of a conduit material sufficiently rigid to resist deformation and closure of said pathway in response to contraction of said myocardium;
a compressible portion connected to said open vessel end, said compressible portion having radial compliance approximately the radial compliance of said vessel; and
a removable sleeve positioned about said compressible portion and holding said compressible portion in a radially compressed state wherein the compressible portion in the compressed state is sized to be inserted into said vessel.
8. A method of establishing a blood flow path through a myocardium between a heart chamber and a lumen of a coronary vessel, the method comprising the steps of:
providing an implant comprising a hollow rigid conduit having a vessel portion and a myocardial portion, said vessel portion sized to be inserted into said vessel, said myocardial portion sized to extend from the vessel portion and through said myocardium into said chamber,
said implant having open vessel and myocardial ends on respective ones of said vessel and myocardial portions to define a blood flow pathway within an interior of said conduit between said vessel and myocardial ends, and a compressible portion connected to said open vessel end, said compressible portion having radial compliance approximately the radial compliance of said vessel;
placing said myocardium portion into said myocardium and inserting said vessel portion and said compressible portion into said coronary vessel.
9. A method according to claim 8, the method further comprising the step of securing said vessel about said vessel portion and said compressible portion with a stay suture about said vessel over only said vessel portion.
US09/304,650 1999-05-04 1999-05-04 Compliant transmyocardial implant Expired - Fee Related US6406491B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US09/304,650 US6406491B1 (en) 1999-05-04 1999-05-04 Compliant transmyocardial implant
PCT/US2000/008105 WO2000066035A1 (en) 1999-05-04 2000-03-27 Compliant transmyocardial implant
GB0128782A GB2369064A (en) 1999-05-04 2000-03-27 Compliant transmyocardial implant
AU39252/00A AU3925200A (en) 1999-05-04 2000-03-27 Compliant transmyocardial implant
JP2000614922A JP2002542882A (en) 1999-05-04 2000-03-27 Elastic myocardial penetration implant
DE10084450T DE10084450T1 (en) 1999-05-04 2000-03-27 Compliant transmyocardial implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/304,650 US6406491B1 (en) 1999-05-04 1999-05-04 Compliant transmyocardial implant

Publications (1)

Publication Number Publication Date
US6406491B1 true US6406491B1 (en) 2002-06-18

Family

ID=23177388

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/304,650 Expired - Fee Related US6406491B1 (en) 1999-05-04 1999-05-04 Compliant transmyocardial implant

Country Status (6)

Country Link
US (1) US6406491B1 (en)
JP (1) JP2002542882A (en)
AU (1) AU3925200A (en)
DE (1) DE10084450T1 (en)
GB (1) GB2369064A (en)
WO (1) WO2000066035A1 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020045928A1 (en) * 2000-05-04 2002-04-18 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20030097170A1 (en) * 2001-09-25 2003-05-22 Curative Ag Implantation device for an aorta in an aortic arch
US6582444B2 (en) 1999-08-04 2003-06-24 Percardia, Inc. Blood flow conduit delivery system and method of use
US6605113B2 (en) 1999-08-04 2003-08-12 Percardia Inc. Vascular graft bypass
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US6610100B2 (en) 1998-09-10 2003-08-26 Percardia, Inc. Designs for left ventricular conduit
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US20050021124A1 (en) * 2003-07-22 2005-01-27 Brendan Cunniffe Stents and stent delivery system
EP1584305A2 (en) * 2004-04-08 2005-10-12 KRAUTH medical KG (GmbH & Co.) Catheter insertable in a blood vessel
EP1584304A1 (en) * 2004-04-08 2005-10-12 KRAUTH medical KG (GmbH & Co.) A conduit for introducing into a blood vessel
US20050288618A1 (en) * 2004-06-24 2005-12-29 Scimed Life Systems, Inc. Myocardial treatment apparatus and method
US20090143713A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Biliary Shunts, Delivery Systems, Methods of Using the Same and Kits Therefor
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20110054381A1 (en) * 2009-05-29 2011-03-03 Jacques Van Dam Biliary shunts, delivery systems, and methods of using the same
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
CN106175979A (en) * 2016-08-05 2016-12-07 武汉麦迪维恩医疗科技有限公司 Artificial blood vessel
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4300244A (en) 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
WO1998006356A1 (en) 1996-08-13 1998-02-19 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
WO1998046115A2 (en) 1997-04-11 1998-10-22 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
WO1999040868A1 (en) 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US6053942A (en) 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5984956A (en) 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4300244A (en) 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
WO1998006356A1 (en) 1996-08-13 1998-02-19 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US5755682A (en) 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
WO1998046115A2 (en) 1997-04-11 1998-10-22 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
WO1999040868A1 (en) 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US6053942A (en) 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US7736327B2 (en) 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8216174B2 (en) 1998-09-10 2012-07-10 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597226B2 (en) 1998-09-10 2013-12-03 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US6610100B2 (en) 1998-09-10 2003-08-26 Percardia, Inc. Designs for left ventricular conduit
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6605113B2 (en) 1999-08-04 2003-08-12 Percardia Inc. Vascular graft bypass
US6582444B2 (en) 1999-08-04 2003-06-24 Percardia, Inc. Blood flow conduit delivery system and method of use
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US20020045928A1 (en) * 2000-05-04 2002-04-18 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20030097170A1 (en) * 2001-09-25 2003-05-22 Curative Ag Implantation device for an aorta in an aortic arch
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US20050021124A1 (en) * 2003-07-22 2005-01-27 Brendan Cunniffe Stents and stent delivery system
US8156942B2 (en) 2003-07-22 2012-04-17 Medtronic Vascular, Inc. Method of implanting a transmyocardial stent
EP1584305A3 (en) * 2004-04-08 2008-02-13 KRAUTH medical KG (GmbH & Co.) Catheter insertable in a blood vessel
EP1584305A2 (en) * 2004-04-08 2005-10-12 KRAUTH medical KG (GmbH & Co.) Catheter insertable in a blood vessel
US20060041244A1 (en) * 2004-04-08 2006-02-23 Reinhard Hohmann Hemocirculatory catheter and method of use thereof
EP1584304A1 (en) * 2004-04-08 2005-10-12 KRAUTH medical KG (GmbH & Co.) A conduit for introducing into a blood vessel
US20050288618A1 (en) * 2004-06-24 2005-12-29 Scimed Life Systems, Inc. Myocardial treatment apparatus and method
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9282968B2 (en) 2007-11-30 2016-03-15 Treus Medical, Inc. Applicator for endoscopic treatment of biliary disease
US20110071350A1 (en) * 2007-11-30 2011-03-24 Jacques Van Dam Applicator for endoscopic treatment of biliary disease
US20090143760A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Gallbladder
US20090143713A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Biliary Shunts, Delivery Systems, Methods of Using the Same and Kits Therefor
US9486219B2 (en) 2007-11-30 2016-11-08 Treus Medical, Inc. Biliary shunts, delivery systems, methods of using the same and kits therefor
US20090143759A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Cystic Duct
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US20110054381A1 (en) * 2009-05-29 2011-03-03 Jacques Van Dam Biliary shunts, delivery systems, and methods of using the same
US9901347B2 (en) 2009-05-29 2018-02-27 Terus Medical, Inc. Biliary shunts, delivery systems, and methods of using the same
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CN106175979A (en) * 2016-08-05 2016-12-07 武汉麦迪维恩医疗科技有限公司 Artificial blood vessel
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry

Also Published As

Publication number Publication date
GB0128782D0 (en) 2002-01-23
JP2002542882A (en) 2002-12-17
WO2000066035A1 (en) 2000-11-09
AU3925200A (en) 2000-11-17
DE10084450T1 (en) 2002-12-05
GB2369064A (en) 2002-05-22

Similar Documents

Publication Publication Date Title
US6406491B1 (en) Compliant transmyocardial implant
US6053942A (en) Transmyocardial implant with coronary stent
US6197050B1 (en) Transmyocardial implant with compliance collar
US6250305B1 (en) Method for using a flexible transmyocardial implant
US6076529A (en) Transmyocardial implant with inserted vessel
US5935119A (en) Perfusion structure
CA2258805C (en) Apparatus and method for surgically accessing a body cavity
US6036702A (en) Medical grafting connectors and fasteners
JP4082736B2 (en) Medical graft connectors and fasteners
US8632555B2 (en) Medical graft connector and methods of making and installing same
US7431691B1 (en) Method and device for improving cardiac function
US8187217B2 (en) TMR shunt
US20040044393A1 (en) Implant system
US20030135269A1 (en) Laparoscopic-assisted endovascular/endoluminal graft placement
US20020077695A1 (en) Medical anastomosis apparatus
US20060036313A1 (en) Apicoaortic conduit connector and method for using
WO2002054987A2 (en) Prosthetic graft device with ventricular apex attachment apparatus
KR20000011113A (en) By-pass graft
US6059821A (en) Method for controlling circulation of blood in a body
AU777443B2 (en) Methods and apparatus for direct coronary revascularization
US20030220661A1 (en) Transmyocardial implant delivery system
US20020082467A1 (en) Prosthetic graft device with ventricular apex attachment apparatus
US7322992B2 (en) Method of removing a fastener
US20020099392A1 (en) Autoanastomosis device and connection technique
US20030216801A1 (en) Transmyocardial implant with natural vessel graft and method

Legal Events

Date Code Title Description
AS Assignment

Owner name: HEARTSTENT CORPORATION, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VANNEY, GUY P.;REEL/FRAME:009943/0114

Effective date: 19990427

AS Assignment

Owner name: PERCARDIA, INC., NEW HAMPSHIRE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HEARTSTENT CORPORATION;REEL/FRAME:014964/0081

Effective date: 20031024

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: HORIZON TECHNOLOGY FUNDING COMPANY LLC, CONNECTICU

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PERCARDIA, INC.;REEL/FRAME:018375/0912

Effective date: 20060701

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362